The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study

Table 1 Demographics of Participants

	PC-PGA (16 subjects, 28 eyes)	PF-PGA (21 subjects, 39 eyes)	PC-PGA + DQS (9 subjects, 17 eyes)	P
Age (y)	63.9 ± 11.6	60.2 ± 15.4	63.9 ± 10.1	0.500^a
Sex (male/female)	6/10	9/12	3/6	0.272^b
IOP (mmHg)	15.8 ± 3.4	16.4 ± 1.8	16.7 ± 2.4	0.528^a
Type of ingredient (Latanoprost/Tafluprost)	14/14	19/20	8/9	0.853^b

Values are represented as mean ± SD
ANOVA = analysis of variance; DQS = diquafosol; IOP = intraocular pressure; PC-PGA = preservative-containing prostaglandin analogs; PC-PGA + DQS = preservative-containing prostaglandin analogs and diquafosol; PF-PGA = preservative-free prostaglandin analogs; SD = standard deviation
^aOne-way ANOVA test
^bChi-square test

ISSN: 1471-2415